THE EFFECT OF APROTININ ON BLOOD PRODUCT REQUIREMENTS DURING ORTHOTOPIC LIVER-TRANSPLANTATION

被引：0
|
作者：
BECHSTEIN, WO
RIESS, H
NEUHAUS, P
HIMMELREICH, G
STEFFEN, R
SLAMA, KJ
ROSSAINT, R
BLUMHARDT, G
机构：
来源：
CLINICAL TRANSPLANTATION | 1991年 / 5卷 / 06期
关键词：
LIVER TRANSPLANTATION; BLOOD TRANSFUSION; APROTININ;
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
The effect of aprotinin, a protease inhibiting agent, on blood product requirements in liver transplantation was investigated in a prospective, open, non-randomized study. From September 1988 until January 1990, 60 consecutive liver transplantations were performed in 56 adult recipients. The first 10 patients (group I) were treated without aprotinin; for the next 50 transplantations (group II) aprotinin was applied in a total dose of 1.5-2.0 mio units i.v. intraoperatively. During primary transplants a mean of 9.7 +/- 5.5 units packed red blood cells (RBC) were substituted in group I vs. 7.5 +/- 4.6 units RBC in group II (n.s.). Fresh frozen plasma was substituted with 10.4 +/- 6.2 (group I) vs. 9.1 +/- 6.7 (group II) units (n.s.). Adverse effects of aprotinin were not observed. The trend towards decreased transfusion requirements and the observation of reduced fibrinolysis prompted us to continue routine use of aprotinin in liver transplantation.
引用
收藏
页码：422 / 426
页数：5
相关论文
共 50 条
  • [31] IMMUNE THROMBOCYTOPENIC PURPURA FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION
    KUO, PC
    LEWIS, WD
    DZIK, W
    JENKINS, RL
    CLINICAL TRANSPLANTATION, 1993, 7 (01) : 43 - 46
  • [32] ORTHOTOPIC LIVER-TRANSPLANTATION IN BUDD-CHIARIS SYNDROME
    BUENO, FS
    PARRILLA, P
    RAMIREZ, P
    MIRAS, M
    ROBLES, R
    PONS, JA
    ACOSTA, F
    NUNEZ, R
    BERMEJO, I
    RODRIGUEZ, JM
    BIXQUERT, V
    ORTEGA, JLS
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1992, 81 (01) : 52 - 56
  • [33] HYPOMAGNESEMIA, CARDIAC-ARRHYTHMIAS AND ORTHOTOPIC LIVER-TRANSPLANTATION
    RANASINGHE, DN
    MALLETT, SV
    ANAESTHESIA, 1994, 49 (05) : 403 - 405
  • [34] Preoperative variables associated with transfusion requirements in orthotopic liver transplantation
    de Santis, Gil Cunha
    Brunetta, Denise Menezes
    Nardo, Mirella
    Oliveira, Luciana Correa
    Souza, Fernanda Fernandes
    Cagnolati, Daniel
    Mente, Enio David
    Sankarankutty, Ajith Kumar
    Covas, Dimas Tadeu
    de Castro e Silva, Orlando
    TRANSFUSION AND APHERESIS SCIENCE, 2014, 50 (01) : 99 - 105
  • [35] CHANGES IN HEMOSTASIS DURING ORTHOTOPIC LIVER-TRANSPLANTATION AND MASSIVE TRANSFUSION - A CASE-REPORT
    KOZEKLANGENECKER, SA
    MULLER, CM
    FELFERNIG, M
    ZIMPFER, M
    INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 1995, 22 (05): : 296 - 300
  • [36] COAGULATION CHANGES AND THE INFLUENCE OF THE EARLY PERFUSATE IN THE COURSE OF ORTHOTOPIC LIVER-TRANSPLANTATION (OLT) WHEN APROTININ IS USED INTRA-OPERATIVELY
    HIMMELREICH, G
    KIERZEK, B
    NEUHAUS, P
    SLAMER, KJ
    JOCHUM, M
    RIESS, H
    BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (01) : 51 - 58
  • [37] POLYAMINE METABOLISM IN THE RAT-LIVER AFTER ORTHOTOPIC LIVER-TRANSPLANTATION
    TERAKURA, M
    HIGAKI, I
    MATSUIYUASA, I
    KINOSHITA, H
    OTANI, S
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1995, 1245 (02): : 207 - 214
  • [38] NODULAR REGENERATIVE HYPERPLASIA - A CONTROVERSIAL INDICATION FOR ORTHOTOPIC LIVER-TRANSPLANTATION
    ELARINY, HA
    MIZRAHI, SS
    HAYES, DH
    BOUDREAUX, JP
    HUSSEY, JL
    FARR, GH
    TRANSPLANT INTERNATIONAL, 1994, 7 (04) : 309 - 313
  • [39] ORTHOTOPIC LIVER-TRANSPLANTATION FOR DANGEROUS AMANTITA-PHALLOIDES POISONING
    POUYET, M
    CAILLON, P
    DUCERF, C
    BERTHAUD, S
    BOUFFARD, Y
    DELAFOSSE, B
    THOMASSON, A
    PIGNAL, C
    PULCE, C
    PRESSE MEDICALE, 1991, 20 (41): : 2095 - 2098
  • [40] BILIARY-TRACT COMPLICATIONS IN PEDIATRIC ORTHOTOPIC LIVER-TRANSPLANTATION
    LALLIER, M
    STVIL, D
    LUKS, FI
    LABERGE, JM
    BENSOUSSAN, AL
    GUTTMAN, FM
    BLANCHARD, H
    JOURNAL OF PEDIATRIC SURGERY, 1993, 28 (09) : 1102 - 1105
12345